Influenza Immunizations in the Elderly: A Continuous Quality Improvement Project

Abstract

As part of the continuous quality improvement program at The Toronto Hospital’s Department of Family & Community Medicine (TTH-DFCM), it was considered necessary to examine the structures, processes and outcomes of influenza immunization for the elderly. Objective: The study sought to (a) document the current influenza immunization process; (b) quantify influenza immunization rates for elderly patients during two consecutive immunization seasons (1996 and 1997), and compare these rates across physician teams, attending staff vs. residents, patient gender, and patient age groups; (c) compare influenza immunization rates with other centers; and (d) identify barriers and propose solutions to improve influenza immunization rates in the elderly. Design: Evaluation Formative Research. Setting: A computerized roster of 15,000 patients at The Toronto Hospital, Department of Family and Community Medicine, a University of Toronto academic teaching center. Participants: Active patients age 65 years and over. Dependent variable: Influenza immunization. Independent variables: Physician Teams, Physician status, Patient gender, and Patient age group. Results: Immunization rates of attendees increased from 75.4% to 78.7%; over 3% increase from 1996 to 1997. Major subgroups which benefited from increased immunization rates were patients in the Blue team, patients age 70-74 years, and female patients. Conclusion: This study presents a rigorous examination of the components of the influenza immunization program, and demonstrates improved immunization rates over a two-year period. Suggestions for future action have been identified. The study design can also serve as a model for future clinical quality improvement projects.

Keywords

Influenza - Immunization - Elderly - Quality Management - Quality Improvement

• REFERENCES

• 1 Canadian Consensus Conference on Influenza. CCDR 1993; 19: 136-42.
• 2 Centers for Disease Control and Prevention.. Influenza prevention and control. www.cdc.gov/ncidod/diseases/flu/fluvirus.htm.
• 3 Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1956-61.
• 4 Gerson LW, Rousseau EW, Hogan TM, Bernstein E, Kalbfleisch N. Multicenter study of case finding in elderly emergency department patients. Acad Emerg Med 1995; 2: 729-34.
• 5 Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-5.
• 6 Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-27.
• 7 Health Care Financing Administration.. Influenza fact sheet for health care providers. http://fightflu.hcfa.goc/provider/flufact.htm
• 8 Health Care Financing Administration.. Influenza vaccination campaign: What?. http://fightflu.hcfa.goc/provider/flufact.htm
• 9 Health Care Financing Administration.. Press Release. Ann Landers urges medicare beneficiaries to get annual flu shot. fightflu.hcfa.goc/flupress.htm
• 10 Honkanen PO, Keistinen T, Kivela SL. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997; 15: 317-20.
• 11 Institute for Advanced Studies in Immunology and Aging.. Improving the performance of influenza and pneumococcal vaccines in adults. Proceedings of a working group meeting Washington, D.C.: 1995
• 12 Lave JR, Ives DG, Traven ND, Kuller LH. Evaluation of a health promotion demonstration program for the rural elderly. Health Services Res 1996; 31: 261-81.
• 13 Levy E, Levy P. Anti-influenza vaccination for active persons (25-64 years): A cost-benefit study. Rev Epidemiol 1992; 40: 285-95.
• 14 Macdonald AJ, Roberecki SA, Cosway NL. Influenza immunization surveillance in rural Manitoba. Can J Pub Health 1996; 87: 163-5.
• 15 Mathias RG. Influenza immunization: Should everyone receive it?. Can J Pub Health 1996; 87: 295-6.
• 16 Medscape.. Facts about influenza for adults. http://www.medscape.com/affiliates/NFID/factsheets/influadult.html
• 17 Michigan Peer Review Organization.. Press Release. Influenza prevention: “Give it your best shot” program. www.pslgroup.com/dg/778a.htm
• 18 MMWR Advisory.. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP). MMWR 46 (RR-9) 1-25.
• 19 MMWR Advisory.. Influenza and pneumococcal vaccination coverage levels among persons aged >65 years – United States, 1973-1993. JAMA 1995; 274: 530-1.
• 20 MMWR Advisory.. Pneumonia and influenza death rates – United States, 1979-1994. JAMA 1995; 274: 532.
• 21 Monto AS. Editorial. Influenza vaccines for the elderly. New Engl J Med 1994; 331: 807-8.
• 22 Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, Rhodes PH. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-52.
• 23 Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl J Med 1994; 331: 778-84.
• 24 Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. Effectiveness of influenza vaccine in the elderly. Gerontology 1996; 42: 274-9.
• 25 Nichol KL, Lind A, Margolis KL, McFadden R, Hauge M, Magnan S, Drake M. The effectiveness of vaccination against influenza in healthy working adults. New Engl J Med 1995; 333: 889-93.
• 26 Ott L. An Introduction to Statistical Methods and Data Analysis. Boston: PWS Publishers; 1984
• 27 Patriarca PP. A randomized controlled trial of influenza vaccine in the elderly – Scientific scrutiny and ethical responsibility. JAMA 1994; 272: 1700-1.
• 28 Patriarca PP, Strikas RA. Influenza vaccine for health adults?. New Engl J Med 1995; 333: 933-4.
• 29 Patton MQ. Qualitative Evaluation and Research Methods, 2nd Ed. Newbury Park: Sage Publications; 1991
• 30 Pneumococcal and influenza vaccination levels among adults aged >65 years – United States. 1993; MMWR 1996; 45: 853-9.
• 31 Rothstein EP, Bernstein HH, Long SS. Immunization of adults. New Engl J Med 1993; 329: 1046-7.
• 32 Sadoway DT, Loucraft JR, Johnston BA. Maximizing influenza immunization in Edmonton: a collaborative model. Can J Pub Health 1994; 85: 47-50.
• 33 Statement on influenza vaccination for the 1995-96 season. CMAJ 1995; 153: 591-7.